In this study, we verify mosaic, activating KRAS pathogenic variants as a cause of CCLA and lymphedema and report what we believe is the first microcystic lymphatic malformation caused by mosaic, activating KRAS pathogenic variants (4, 32). The gene discussed is KRAS; the disease is lymphedema.